CVKD
Price
$3.06
Change
-$0.12 (-3.77%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
9.42M
44 days until earnings call
Intraday BUY SELL Signals
PBM
Price
$2.97
Change
-$0.13 (-4.19%)
Updated
Jun 23, 04:56 PM (EDT)
Capitalization
6.67M
Intraday BUY SELL Signals
Interact to see
Advertisement

CVKD vs PBM

CVKD vs PBM Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CVKD vs. PBM commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVKD is a Hold and PBM is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (CVKD: $3.20 vs. PBM: $3.10)
Brand notoriety: CVKD and PBM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVKD: 96% vs. PBM: 3%
Market capitalization -- CVKD: $9.87M vs. PBM: $7.11M
CVKD [@Biotechnology] is valued at $9.87M. PBM’s [@Biotechnology] market capitalization is $7.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVKD’s FA Score shows that 0 FA rating(s) are green whilePBM’s FA Score has 1 green FA rating(s).

  • CVKD’s FA Score: 0 green, 5 red.
  • PBM’s FA Score: 1 green, 4 red.
According to our system of comparison, PBM is a better buy in the long-term than CVKD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVKD’s TA Score shows that 3 TA indicator(s) are bullish while PBM’s TA Score has 4 bullish TA indicator(s).

  • CVKD’s TA Score: 3 bullish, 2 bearish.
  • PBM’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CVKD is a better buy in the short-term than PBM.

Price Growth

CVKD (@Biotechnology) experienced а -3.75% price change this week, while PBM (@Biotechnology) price change was -6.06% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

CVKD is expected to report earnings on Aug 06, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CVKD($9.42M) has a higher market cap than PBM($6.67M). PBM YTD gains are higher at: -34.165 vs. CVKD (-52.729). PBM has higher annual earnings (EBITDA): -3.93M vs. CVKD (-12.05M). PBM has more cash in the bank: 7.15M vs. CVKD (2.31M). CVKD has less debt than PBM: CVKD (0) vs PBM (2.5M). CVKD (0) and PBM (0) have equivalent revenues.
CVKDPBMCVKD / PBM
Capitalization9.42M6.67M141%
EBITDA-12.05M-3.93M307%
Gain YTD-52.729-34.165154%
P/E RatioN/A0.04-
Revenue00-
Total Cash2.31M7.15M32%
Total Debt02.5M-
TECHNICAL ANALYSIS
Technical Analysis
CVKDPBM
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
83%
Stochastic
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
Momentum
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 6 days ago
80%
Bullish Trend 29 days ago
79%
Declines
ODDS (%)
Bearish Trend 8 days ago
85%
Bearish Trend 8 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CVKD
Daily Signal:
Gain/Loss:
PBM
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TPC81.503.51
+4.50%
Tutor Perini Corp
ANTA6.50-0.04
-0.61%
Antalpha Platform Holding Company
NTR62.25-0.61
-0.97%
Nutrien Ltd
AMPH18.32-0.49
-2.60%
Amphastar Pharmaceuticals
RVSN4.26-0.13
-3.07%
Rail Vision Ltd

CVKD and

Correlation & Price change

A.I.dvisor indicates that over the last year, CVKD has been loosely correlated with ARDX. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if CVKD jumps, then ARDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVKD
1D Price
Change %
CVKD100%
-8.43%
ARDX - CVKD
35%
Loosely correlated
+5.29%
RADX - CVKD
31%
Poorly correlated
-3.15%
VIR - CVKD
30%
Poorly correlated
+4.48%
GDTC - CVKD
29%
Poorly correlated
N/A
NKTX - CVKD
28%
Poorly correlated
-2.27%
More

PBM and

Correlation & Price change

A.I.dvisor indicates that over the last year, PBM has been loosely correlated with NRSN. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if PBM jumps, then NRSN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PBM
1D Price
Change %
PBM100%
-1.59%
NRSN - PBM
37%
Loosely correlated
-3.70%
BCAB - PBM
32%
Poorly correlated
+0.14%
OBIO - PBM
27%
Poorly correlated
+1.75%
CVKD - PBM
27%
Poorly correlated
-8.43%
BCRX - PBM
27%
Poorly correlated
+1.67%
More